Insulet
PODD
#1895
Rank
HK$86.02 B
Marketcap
HK$1,242
Share price
-0.35%
Change (1 day)
-44.81%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total debt

Total debt on the balance sheet as of March 2026 : HK$7.43 Billion

According to Insulet's latest financial reports the company's total debt is HK$7.43 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insulet - Total debt on balance sheet (from 2005 to 2026)

Total debt by year

Year Total debt Change
2025-12-31HK$7.38 B-31.06%
2024-12-31HK$10.71 B-3.12%
2023-12-31HK$11.05 B0.96%
2022-12-31HK$10.95 B10.26%
2021-12-31HK$9.93 B20.96%
2020-12-31HK$8.21 B18.75%
2019-12-31HK$6.91 B49.16%
2018-12-31HK$4.63 B4.8%
2017-12-31HK$4.42 B71.42%
2016-12-31HK$2.58 B87.58%
2015-12-31HK$1.37 B4.53%
2014-12-31HK$1.31 B39.47%
2013-12-31HK$0.94 B3.02%
2012-12-31HK$0.91 B8.64%
2011-12-31HK$0.84 B56.02%
2010-12-31HK$0.54 B-28.14%
2009-12-31HK$0.75 B61.72%
2008-12-31HK$0.46 B123.55%
2007-12-31HK$0.20 B-8.48%
2006-12-31HK$0.22 B199.7%
2005-12-31HK$75.83 M88613.37%
2004-12-31HK$0.08 M0.26%
2003-12-31HK$0.08 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$431.18 B 5,699.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$266.98 B 3,491.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$219.25 B 2,849.16%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$340.08 B 4,474.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
HK$5.76 B-22.50%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
HK$10.39 B 39.84%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$10.85 B 46.06%๐Ÿ‡บ๐Ÿ‡ธ USA